s6y
Company name or ticker
Search
Opus Genetics, Inc.
424B5
Prospectus filed pursuant to Rule 424(b)(5)
Filed
Monday, March 16, 2015
Accession number
0001140361-15-011987
Documents
REXAHN PHARMACEUTICALS, INC 424B5 3-16-2015
424B5
On sec.gov
Filing index
All files
Complete submission text
SGML header